Cite
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial.
MLA
Goldstein, Daniel J., et al. “Intimal Hyperplasia, Saphenous Vein Graft Disease, and Clinical Outcomes: Insights from the CTSN VEST Randomized Trial.” Journal of Thoracic & Cardiovascular Surgery, vol. 167, no. 5, May 2024, p. 1782. EBSCOhost, https://doi.org/10.1016/j.jtcvs.2022.10.034.
APA
Goldstein, D. J., Chang, H. L., Mack, M. J., Voisine, P., Gammie, J. S., Marks, M. E., Iribarne, A., Vengrenyuk, Y., Raymond, S., Taylor, B. S., Dagenais, F., Ailawadi, G., Chu, M. W. A., DiMaio, J. M., Narula, J., Moquete, E. G., O’Sullivan, K., Williams, J. B., Crestanello, J. A., & Scavo, V. (2024). Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial. Journal of Thoracic & Cardiovascular Surgery, 167(5), 1782. https://doi.org/10.1016/j.jtcvs.2022.10.034
Chicago
Goldstein, Daniel J., Helena L. Chang, Michael J. Mack, Pierre Voisine, James S. Gammie, Mary E. Marks, Alexander Iribarne, et al. 2024. “Intimal Hyperplasia, Saphenous Vein Graft Disease, and Clinical Outcomes: Insights from the CTSN VEST Randomized Trial.” Journal of Thoracic & Cardiovascular Surgery 167 (5): 1782. doi:10.1016/j.jtcvs.2022.10.034.